Last updated: January 28, 2021
Sponsor: Poitiers University Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Allergy
Rash
Eczema (Atopic Dermatitis)
Treatment
N/AClinical Study ID
NCT04274348
2019-A01904-53
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients with moderate AD (SCORAD between 25 and 50) or severe AD (SCORAD> 50)
- Skin lesions in the forearms
- Free subject, without neither guardianship, wardship nor subordination
- Patient with Social Security
- Informed and signed consent by the patient after clear and loyal information on thestudy
Exclusion
Exclusion Criteria:
- Age < 18 year-old
- Patients with mild AD (SCORAD < 25)
- Patients without skin lesions in the forearms
- Patients treated with dermocorticoid or calcineurin inhibitor for less than two weeks
- Patients under systemic treatment : Methotrexate, Ciclosporin, Mycophenolate Mofetil,Azathioprine, general corticosteroids for less than 4 weeks
- Patients under biological treatment : Dupilumab for less than 5 half-lives
- Patient without Social Security
- Pregnant and nursing women
Study Design
Total Participants: 80
Study Start date:
October 15, 2020
Estimated Completion Date:
October 16, 2023
Connect with a study center
CHU de Bordeaux
Bordeaux,
FranceActive - Recruiting
CHU de Poitiers
Poitiers,
FranceActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.